WHO announces plans to establish a TB Vaccine Accelerator Council

The Council will facilitate the licensing and use of effective novel TB vaccines catalysing high-level alignment between funders, global agencies, governments and end users in identifying and overcoming barriers to TB vaccine development.

Read More →

Updates from the 1/4/6x24 Campaign

A few recent Campaign updates from Treatment Action Group and allies.
Contact david.branigan@treatmentactiongroup.org for more information on how to be part of the 1/4/6x24 Campaign.

Read More →

Urgent action necessary to improve equitable access to bedaquiline-based regiments and achieve 1/4/6×24

Advocates urge Johnson & Johnson to correct its course and stop blocking entry of generic versions of bedaquiline into the global market and into countries.

Read More →

India must reject Johnson & Johnson’s attempt to extend monopoly on lifesaving TB drug bedaquiline

Médecins Sans Frontières urges the Indian Patent Office to reject the secondary patent application filed by Johnson & Johnson to prevent the company from extending its monopoly on bedaquiline beyond the primary patent’s expiry in July 2023.

Read More →

WHO announces landmark changes in treatment of drug-resistant TB

The World Health Organization releases updated guidelines and a supporting operational handbook on the treatment of drug-resistant TB featuring major improvements in treatment options for people with multidrug-resistant or rifampicin-resistant TB.

Read More →

GFAN selected for UN High-Level Meeting Affected Communities and Civil Society Platform

GFAN is selected to coordinate the Affected Communities and Civil Society Platform for the 2023 UN High-Level Meeting on TB. Applications are now being accepted for lead consultant(s) to support this work (Deadline: 5 January 2023).

Read More →

GCTA report launched: Innovative TB Community Service Delivery during the COVID-19 Pandemic

Innovative TB Community Service Delivery during the COVID-19 Pandemic: Best Practices and Lessons Learned from Cambodia, India, Indonesia, and Kenya

Read More →

New manual on IGRA tests for TB infection launched

The manual provides an overview of the recommended use of IGRAs as a class of in-vitro tests for the detection of TB infection and describes their performance, steps for use and implementation considerations.

Read More →

An investment case for new TB vaccines

A document summarizes the results of the WHO-commissioned full value proposition for new TB vaccines.

Read More →

Worldwide TB R&D funding surpasses US$1 billion, but falls short of goals

A report highlights that despite reaching US$1 billion in spending in 2021, funding for TB R&D is a mere fraction of what’s needed to achieve UN sustainable development goal of ending TB as a pandemic by 2030.

Read More →

Page 1 of 119 · Total posts: 10

1 2 Last→